It's still January, and different levels of stringency to hurdle over in gaining approval apply to different medical products. Software like HepaFat Scan (Resonance Health) would pass the FDA approval process much easier/faster than implantables like Cardiocel. Thanks for the reminder about the govt shutdown. Hearing back before June seems realistic (though Lee Rodne definitely knows what he's doing so it might be even earlier).
recent price action, page-17
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
-0.300(1.64%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.29 | $18.30 | $17.65 | $181.7K | 10.18K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30 | $17.72 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.00 | 499 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |